Target intelligence / Profile preview

Protocadherin beta-6 (PCDHB6)

Target
PCDHB6
Molecular classification
Cell adhesion molecule, Protocadherin, Transmembrane glycoprotein
01

Overview

Protocadherin beta-6 is a calcium-dependent cell-adhesion protein belonging to the protocadherin beta gene cluster, part of the cadherin superfamily. It is an integral plasma membrane protein crucial for neuronal self-recognition and non-self discrimination, allowing the establishment and maintenance of specific neuronal connections in the brain. Its highly diverse isoforms are stochastically and monoallelically expressed in individual neurons, providing unique adhesive identities that help ensure appropriate neural wiring. Protocadherin beta-6 is primarily expressed in neural tissues. Disruption or mutation of PCDHB6 has been implicated in certain neurodevelopmental disorders, including Autism spectrum disorder and Cornelia de Lange syndrome. Alternative splicing generates multiple transcript variants. The molecular mechanism involves homophilic (isoform- and cell-specific) adhesive recognition via its extracellular cadherin domains. However, Protocadherin beta-6 is not an established drug target, and there are currently no known disease-modifying drugs or clinical biomarkers associated specifically with this protein.

Other names
Protocadherin beta-6PCDHB6PCDH-beta-6PCDH-BETA6protocadherin β 6
02

Mechanism of action

Not applicable; no drugs with a described mechanism of action targeting this protein.

03

Biological functions

Cell adhesion (calcium-dependent)Cell self-recognition and non-self discriminationEstablishment and maintenance of specific neuronal connections in the brain
04

Disease associations

Neurodevelopmental disorders (notably Autism spectrum disorder and Cornelia de Lange syndrome are associated with mutations or disruptions)Potential other neurological/neuropsychiatric diseases (limited evidence)No strong evidence linking directly to cancer, inflammation, neurodegeneration, or other major disease classes.

Beyond the preview

Go deeper on Protocadherin beta-6 (PCDHB6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin beta-6 (PCDHB6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call